(Q33787916)

29 July 2017

Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B (English)

1 reference

29 July 2017

0 references

1 reference

1 reference

Giada Sebastiani

1

1 reference

29 July 2017

Alessandro Vario

series ordinal

2

1 reference

29 July 2017

Maria Guido

series ordinal

3

1 reference

29 July 2017

Alfredo Alberti

series ordinal

4

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

World Journal of Gastroenterology

29 July 2017

1 reference

29 July 2017

13

1 reference

29 July 2017

4

1 reference

29 July 2017

525-531

1 reference

Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

Glucose abnormalities in patients with hepatitis C virus infection: Epidemiology and pathogenesis.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

Evaluation of liver fibrosis: a concise review

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

Liver biopsy sampling in chronic viral hepatitis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

Diagnosis, management, and treatment of hepatitis C

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

Watchful waiting with periodic liver biopsy versus immediate empirical therapy for histologically mild chronic hepatitis C. A cost-effectiveness analysis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

Natural history and prognostic factors for chronic hepatitis type B

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

Sources of variability in histological scoring of chronic viral hepatitis

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

Serum laminin-2 and hyaluronan predict severe liver fibrosis in children with chronic hepatitis B.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

Sampling variability of liver fibrosis in chronic hepatitis C.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

Liver biopsy size matters in chronic hepatitis: bigger is better

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

Liver biopsy in chronic aggressive hepatitis. Diagnostic reproducibility in relation to size of specimen

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065973

Ultrasound-assisted percutaneous liver biopsy performed by a physician assistant

30 October 2018

1 reference

12 December 2020

Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B

1 reference

12 December 2020

[Medical practices and expectations of general practitioners in relation to hepatitis C virus infection in the Auvergne region]

1 reference

12 December 2020

Chronic hepatitis B: update of recommendations

1 reference

12 December 2020

Survival in chronic hepatitis B. An analysis of 379 patients

1 reference

12 December 2020

Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies

1 reference

12 December 2020

Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group

1 reference

12 December 2020

Histological grading and staging in chronic hepatitis: clinical applications and problems

1 reference

12 December 2020

Experts' opinions on the role of liver biopsy in HCV infection: A Delphi survey by the Italian Association of Hospital Gastroenterologists (A.I.G.O.)

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V13.I4.525

1 reference

29 July 2017

1 reference

29 July 2017

1 reference